BioRestorative Therapies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BioRestorative Therapies generated cash of -$6,430,211, which is less than the previous year. Cash used in financing activities reached the amount of $2,348,773 last year. Net change in cash is therefore -$829,395.
Cash Flow
| 2014 | -3.22M | -167.39K | 3.28M |
|---|---|---|---|
| 2015 | -3.12M | -483.06K | 3.67M |
| 2016 | -5.00M | -188.76K | 5.05M |
| 2017 | -3.85M | -3.61K | 4.27M |
| 2018 | -5.10M | -12.86K | 4.78M |
| 2019 | -6.91M | -35.63K | 6.83M |
| 2020 | -1.96M | 0 | 5.02M |
| 2021 | -3.32M | -30.65K | 21.32M |
| 2022 | -5.87M | -13.47M | 0 |
| 2023 | -6.43M | 3.25M | 2.34M |
BRTX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.71M | 21.02M | 3.06M | 1.66K | 117.52K | 451.68K | 31.82K | 166.55K | 91.79K | 201.09K |
Operating activities | ||||||||||
Net income | -10.41M | -18.49M | -44.30M | -11.27M | -14.64M | -12.51M | -9.44M | -8.63M | -7.92M | -5.58M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 165.73K | 120.54K | 89.10K | 121.38K | 217.35K | 240.37K | 259.25K | 258.42K | 213.78K | 96.68K |
Stock-based compensation expense | 7.78M | 12.61M | 23.10M | 691.70K | 1.65M | 0 | 3.60M | 2.53M | 1.95M | 1.36M |
| Deferred income tax benefit | 7.78M | 12.61M | 23.10M | 691.70K | 1.65M | 0 | 3.60M | 2.53M | 1.95M | 1.36M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -11K | 12K | 15K | -3K | 9K | -32K | 87.37K | -93.37K | 597.1K |
Inventories | 0 | 0 | 0 | 0 | 423.65K | 9.53M | 655.28K | 5.98M | 934.59K | 613 |
Accounts payable | 18.48K | 120.07K | -68.02K | 84.63K | 97.09K | -516.11K | 185.96K | -113.15K | 1.38M | -234.56K |
Cash generated by operating activities | -6.43M | -5.87M | -3.32M | -1.96M | -6.91M | -5.10M | -3.85M | -5.00M | -3.12M | -3.22M |
Investing activities | ||||||||||
Purchases Of Investments | -17.54M | -13.03M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -171.04K | -440.22K | -30.65K | 0 | -35.63K | -12.86K | -3.61K | -188.76K | -483.06K | -168.37K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 3.25M | -13.47M | -30.65K | 0 | -35.63K | -12.86K | -3.61K | -188.76K | -483.06K | -167.39K |
Financing activities | ||||||||||
Common Stock Issued | 2.34M | 0 | 21.07M | 10K | 1.65M | 0 | 1.08M | 3.49M | 2.03M | 2.60M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -250K | -4.29M | 5.18M | -4.19M | 2.21M | -476.5K | 1.20M | -202.06K |
Cash used in financing activities | 2.34M | 0 | 21.32M | 5.02M | 6.83M | 4.78M | 4.27M | 5.05M | 3.67M | 3.28M |
Net Change In Cash | -829.39K | -19.35M | 17.96M | 3.06M | -115.85K | -334.15K | 419.85K | -134.73K | 74.75K | -109.3K |
Cash at end of period | 884.37K | 1.67M | 21.02M | 3.06M | 1.66K | 117.52K | 451.68K | 31.82K | 166.55K | 91.79K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |